Role of activity and fibrosis in the MASLD atherogenic momentum through advanced lipidomics
PLOS One · 13.05.2026 · 21 (5) · e0343134
DOI: 10.1371/journal.pone.0343134 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 13.05.2026. Verfasst von Agustín Blanco-Echevarría und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Lípidos y Riesgo Vascular. Servicio de Medicina Interna. Hospital Universitario 12 de Octubre. Madrid, Spain. Hauptthemen laut MEDLINE: Lipidomics, Liver Cirrhosis, Atherosclerosis, Dyslipidemias. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
MASLD is linked to dyslipidemia, but it remains unclear whether this alteration depends more on disease activity or fibrosis.
Objective
To determine whether dyslipidemia is primarily associated with activity and/or fibrosis through standard lipid profile and advanced lipidomics.
Methods
A cross-sectional study was conducted including patients with suspected MASLD at a single center. Intraoperative liver biopsies were obtained. Only patients with MASLD were included in the analysis. Histological activity was defined as a NAFLD Activity Score (NAS) ≥5 and fibrosis was staged according to standard criteria. Clinical, biochemical, lipoprotein, and fatty acid profiles were assessed, including nuclear magnetic resonance (NMR) spectroscopy for lipoprotein subfractions and gas chromatography for fatty acids. Multivariable linear regression models were used to evaluate independent associations of activity and fibrosis with lipid parameters.
Results
A total of 49 patients were analyzed (mean age 48 years, 46% men, 94% with BMI > 35). Liver biopsies revealed a 30.6% prevalence of activity (NAS ≥ 5) and 36.7% of fibrosis. Higher lipid levels in patients with activity were related to apolipoprotein B, non-HDL cholesterol, and triglycerides in both univariate and multivariate models. Fibrosis was not associated with any lipid parameter. Lipidomics confirmed associations of activity with VLDL+IDL cholesterol (β = 0.474, 95% CI 0.204–0.745, p = 0.001), VLDL+IDL triglycerides (β = 0.454, 95% CI 0.198–0.710, p = 0.001), and VLDL particle concentration (β = 0.409, 95% CI 0.155–0.663, p = 0.002), and showed a trend toward an inverse association with the percentage of large VLDL particles (β=−0.298, 95% CI −0.602–0.006, p = 0.054). Besides, the omega-6/triglycerides ratio was inversely associated with activity (β=−0.345, 95% CI −0.630 to −0.060, p = 0.019).
Conclusion
Hepatic inflammatory activity showed strong associations with a non-traditional atherogenic lipidomic profile. These findings suggest that activity, rather than liver fibrosis, may be a key factor in the MASLD atherosclerotic momentum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unidad de Lípidos y Riesgo Vascular. Servicio de Medicina Interna. Hospital Universitario 12 de Octubre. Madrid, Spain.
- Universidad Complutense de Madrid.
- Instituto de Investigación Biomédica. Hospital Universitario 12 de Octubre "I+12".
- Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Fundación Hospital Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain.
- Área de Medicina Vascular, Departamento de Endocrinología, Clínica Universidad de Navarra, Madrid, Spain.
- Servicio de Medicina Aparato Digestivo, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
ORCID-Profile: Ramón Costa Segovia, Carlos Guijarro Herraiz, Yolanda Rodríguez Gil, Nuria Amigó, Diego Martínez-Urbistondo
Zitieren
APA
Blanco-Echevarría, A., Costa Segovia, R., Guijarro Herraiz, C., García Izquierdo, B., Guadalix, S., Pérez Carreras, M., Rodríguez Gil, Y., de Castro Martínez, M., Amigó, N., D'Avola, D., Lumbreras Bermejo, C., & Martínez-Urbistondo, D. (2026). Role of activity and fibrosis in the MASLD atherogenic momentum through advanced lipidomics. PLOS One, 21(5), e0343134. https://doi.org/10.1371/journal.pone.0343134
Vancouver
Blanco-Echevarría A, Costa Segovia R, Guijarro Herraiz C, García Izquierdo B, Guadalix S, Pérez Carreras M, et al. Role of activity and fibrosis in the MASLD atherogenic momentum through advanced lipidomics. PLOS One. 2026;21(5):e0343134. doi:10.1371/journal.pone.0343134
BibTeX
@article{BlancoEchevarra2026,
author = {Blanco-Echevarría, Agustín and Costa Segovia, Ramón and Guijarro Herraiz, Carlos and García Izquierdo, Belén and Guadalix, Sonsoles and Pérez Carreras, Mercedes and Rodríguez Gil, Yolanda and de Castro Martínez, Marta and Amigó, Nuria and D'Avola, Delia and Lumbreras Bermejo, Carlos and Martínez-Urbistondo, Diego},
title = {Role of activity and fibrosis in the MASLD atherogenic momentum through advanced lipidomics},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0343134},
doi = {10.1371/journal.pone.0343134}
}
EUVIMED